SCHEMBL6072350

SCHEMBL6072350

Cc1c(C(=O)N2CCNCC2)nnn1CCCN1CCCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
GAA P10253 1/20 0.39
HPGD P15428 2/20 0.38
CYP2C19 P33261 2/20 0.38
MEN1 O00255 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CXCR4 P61073 2/20 0.37
POLB P06746 1/20 0.36
KDM4E B2RXH2 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
HRH3 Q9Y5N1 4/20 0.33
HRH4 Q9H3N8 1/20 0.33
CA2 P00918 1/20 0.33
CHKA P35790 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL8834772 0.93 PKM (0.39) ALDH1A1GAAHPGDCYP2C19MEN1
SCHEMBL5794435 0.80 PRKCI (0.39) ALDH1A1KMT2A
Trifluoroacetic Acid SCHEMBL8834402 0.79 PKM (0.40) ALDH1A1GAAHPGDCYP2C19MEN1
SCHEMBL8834397 0.78 PKM (0.34) ALDH1A1GAAHPGDCYP2C19MEN1
Trifluoroacetic Acid SCHEMBL8834836 0.75 TBXAS1 (0.41)
SCHEMBL6071728 0.73 CYP19A1 (0.48) GAAHPGDMEN1CYP1A2KMT2A
SCHEMBL6071882 0.72 CYP19A1 (0.45) ALDH1A1GAAHPGDMEN1CYP1A2
SCHEMBL5795235 0.71 KCNJ1 (0.53) ALDH1A1KMT2APOLBKDM4EHRH3
Trifluoroacetic Acid SCHEMBL8834878 0.71 PKM (0.41) ALDH1A1GAAHPGDCYP2C19MEN1
SCHEMBL5795346 0.70 KDM1A (0.48) ALDH1A1HPGDMEN1CYP2C9KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060160794-A1 Tachykinin receptor antagonists ELI LILLY AND COMPANY 2006-07-20 US claimed
US-20060160794-A1 Tachykinin receptor antagonists ELI LILLY AND COMPANY 2006-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160794-A1 Tachykinin receptor antagonists TACR1, TACR2, PROKR1 ALDH1A1 1815/4885GAA 1942/4885HPGD 1291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.